Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

TELA Bio (TELA) Share-based Compensation (2018 - 2026)

TELA Bio has reported Share-based Compensation over the past 8 years, most recently at $812000.0 for Q4 2025.

For Q4 2025, Share-based Compensation fell 25.44% year-over-year to $812000.0; the TTM value through Dec 2025 reached $3.8 million, down 12.98%, while the annual FY2025 figure was $3.8 million, 12.98% down from the prior year.
Share-based Compensation for Q4 2025 was $812000.0 at TELA Bio, down from $955000.0 in the prior quarter.
Over five years, Share-based Compensation peaked at $1.4 million in Q2 2021 and troughed at $694000.0 in Q1 2021.
A 5-year average of $1.0 million and a median of $1.0 million in 2022 define the central range for Share-based Compensation.
Biggest five-year swings in Share-based Compensation: surged 185.83% in 2021 and later decreased 27.62% in 2022.
Year by year, Share-based Compensation stood at $822000.0 in 2021, then increased by 26.4% to $1.0 million in 2022, then grew by 19.44% to $1.2 million in 2023, then dropped by 12.25% to $1.1 million in 2024, then decreased by 25.44% to $812000.0 in 2025.
Business Quant data shows Share-based Compensation for TELA at $812000.0 in Q4 2025, $955000.0 in Q3 2025, and $985000.0 in Q2 2025.